You can find the annual or quarterly income statement of Design Therapeutics Inc here for insights into the performance and operational efficiency of Design Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q2

FY2020Q1

Total revenue

----

--0.00

-100.00%0.00

--31.00K

--142.00K

Revenue

----

--0.00

-100.00%0.00

--31.00K

--142.00K

Operating expenses

8.84%18.17M

18.87%19.31M

43.38%21.57M

41.79%20.42M

10.40%16.69M

-13.69%16.25M

-33.43%15.04M

-33.49%14.40M

-22.02%15.12M

-1.93%18.82M

44.48%22.60M

61.94%21.65M

74.28%19.39M

69.29%19.19M

103.45%15.64M

135.39%13.37M

--11.13M

--11.34M

414.52%7.69M

642.48%5.68M

--1.49M

--765.00K

R&D expenses

10.43%13.43M

22.84%14.59M

49.66%15.74M

56.89%15.38M

10.40%12.16M

-10.42%11.88M

-38.37%10.52M

-37.69%9.80M

-22.75%11.01M

-7.32%13.26M

51.08%17.06M

79.59%15.73M

94.29%14.26M

67.51%14.30M

124.69%11.29M

126.04%8.76M

--7.34M

--8.54M

373.80%5.03M

927.85%3.88M

--1.06M

--377.00K

Depreciation, depletion, and amortization

4.70%156.00K

1.31%155.00K

0.66%152.00K

11.19%159.00K

7.97%149.00K

11.68%153.00K

13.53%151.00K

10.85%143.00K

11.29%138.00K

26.85%137.00K

44.57%133.00K

57.32%129.00K

51.22%124.00K

248.39%108.00K

666.67%92.00K

1950.00%82.00K

--82.00K

--31.00K

--12.00K

--4.00K

----

Operating profit

-8.84%-18.17M

-18.87%-19.31M

-43.38%-21.57M

-41.79%-20.42M

-10.40%-16.69M

13.69%-16.25M

33.43%-15.04M

33.49%-14.40M

22.02%-15.12M

1.93%-18.82M

-44.48%-22.60M

-61.94%-21.65M

-74.28%-19.39M

-69.29%-19.19M

-103.45%-15.64M

-135.39%-13.37M

---11.13M

---11.34M

-425.43%-7.69M

-811.72%-5.68M

---1.46M

---623.00K

Net non-operating interest income (expenses)

Non-operating interest income

----

--2.70M

----

Other non-operating income (expenses)

-28.62%2.17M

-27.85%2.31M

-23.51%2.49M

-17.97%2.70M

-7.20%3.04M

5.74%3.21M

22.23%3.25M

39.80%3.29M

59.80%3.28M

103.83%3.03M

315.47%2.66M

2144.76%2.36M

3209.68%2.05M

7731.58%1.49M

1154.90%640.00K

-36.75%105.00K

--62.00K

--19.00K

142.86%51.00K

515.00%166.00K

--21.00K

---40.00K

Income before tax

-17.19%-16.00M

-30.36%-17.00M

-61.82%-19.08M

-59.52%-17.71M

-15.28%-13.65M

17.42%-13.04M

40.85%-11.79M

42.44%-11.11M

31.71%-11.84M

10.82%-15.79M

-32.92%-19.94M

-45.45%-19.29M

-56.71%-17.34M

-56.42%-17.70M

-96.42%-15.00M

-140.57%-13.27M

---11.06M

---11.32M

-429.54%-7.64M

-731.67%-5.51M

---1.44M

---663.00K

Income after tax

-17.19%-16.00M

-30.36%-17.00M

-61.82%-19.08M

-59.52%-17.71M

-15.28%-13.65M

17.42%-13.04M

40.85%-11.79M

42.44%-11.11M

31.71%-11.84M

10.82%-15.79M

-32.92%-19.94M

-45.45%-19.29M

-56.71%-17.34M

-56.42%-17.70M

-96.42%-15.00M

-140.57%-13.27M

---11.06M

---11.32M

-429.54%-7.64M

-731.67%-5.51M

---1.44M

---663.00K

Net income from continuous operations

-17.19%-16.00M

-30.36%-17.00M

-61.82%-19.08M

-59.52%-17.71M

-15.28%-13.65M

17.42%-13.04M

40.85%-11.79M

42.44%-11.11M

31.71%-11.84M

10.82%-15.79M

-32.92%-19.94M

-45.45%-19.29M

-56.71%-17.34M

-56.42%-17.70M

-96.42%-15.00M

-140.57%-13.27M

---11.06M

---11.32M

-429.54%-7.64M

-731.67%-5.51M

---1.44M

---663.00K

Net income attributable to controlling interests

-17.19%-16.00M

-30.36%-17.00M

-61.82%-19.08M

-59.52%-17.71M

-15.28%-13.65M

17.42%-13.04M

40.85%-11.79M

42.44%-11.11M

31.71%-11.84M

10.82%-15.79M

-32.92%-19.94M

-45.45%-19.29M

-56.71%-17.34M

-56.42%-17.70M

-96.42%-15.00M

-140.57%-13.27M

---11.06M

---11.32M

-429.54%-7.64M

-731.67%-5.51M

---1.44M

---663.00K

Net income attributable to common shareholders

-17.19%-16.00M

-30.36%-17.00M

-61.82%-19.08M

-59.52%-17.71M

-15.28%-13.65M

17.42%-13.04M

40.85%-11.79M

42.44%-11.11M

31.71%-11.84M

10.82%-15.79M

-32.92%-19.94M

-45.45%-19.29M

-56.71%-17.34M

-56.42%-17.70M

-96.42%-15.00M

-140.57%-13.27M

---11.06M

---11.32M

-429.54%-7.64M

-731.67%-5.51M

---1.44M

---663.00K

Basic earnings per share

-13.06%-0.27

-29.60%-0.30

-60.95%-0.34

-58.77%-0.31

-14.07%-0.24

18.34%-0.23

41.48%-0.21

43.03%-0.20

31.98%-0.21

11.15%-0.28

-32.26%-0.36

-44.41%-0.35

-55.59%-0.31

-54.67%-0.32

-94.34%-0.27

23.59%-0.24

---0.20

---0.21

-146.10%-0.14

-1106.64%-0.31

---0.06

---0.03

Diluted earnings per share

-13.06%-0.27

-29.60%-0.30

-60.95%-0.34

-58.77%-0.31

-14.07%-0.24

18.34%-0.23

41.48%-0.21

43.03%-0.20

31.98%-0.21

11.15%-0.28

-32.26%-0.36

-44.41%-0.35

-55.59%-0.31

-54.67%-0.32

-94.34%-0.27

23.59%-0.24

---0.20

---0.21

-146.10%-0.14

-1106.64%-0.31

---0.06

---0.03

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

